Upregulation of lncRNA SATB1‐AS1 in Serum Promotes Sepsis Progression By Suppressing miR‐124‐3p and Enhancing Inflammatory Mediator Release
Journal of Biochemical and Molecular Toxicology · 2026-06 · 40 (6)
DOI: 10.1002/jbt.70929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 10.06.2026. Verfasst von Lihong Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Sepsis, RNA, Long Noncoding, Up-Regulation. Die Arbeit nennt 45 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life‐threatening systemic inflammatory response syndrome. The long non‐coding RNA SATB1‐AS1 exhibits abnormal expression in blood samples from sepsis patients. This study explores the regulatory role of SATB1‐AS1 in sepsis. This study included 58 patients with sepsis and 42 patients with non‐septic infections. RT‐qPCR was used to detect the expression levels of SATB1‐AS1 and miR‐124‐3p. ROC analysis evaluated the diagnostic value of SATB1‐AS1. In an LPS‐induced RAW264.7 sepsis model, macrophage differentiation markers, cell proliferation, apoptosis, and inflammatory factor levels were assessed via RT‐qPCR, CCK‐8 assay, flow cytometry, and ELISA, respectively. DLR and RIP experiments validated the binding relationship between SATB1‐AS1 and miR‐124‐3p. SATB1‐AS1 was significantly overexpressed in the serum of sepsis patients, demonstrating good diagnostic value. Conversely, miR‐124‐3p is downregulated, with both molecules exhibiting targeted binding and negatively correlated expression levels. Knocking down SATB1‐AS1 increases miR‐124‐3p levels, enhances cellular proliferation, reduces apoptosis rates, promotes macrophage M2 polarization, and decreases TNF‐α, IL‐6, and IL‐1β release. SATB1‐AS1 holds promise as a novel diagnostic biomarker for sepsis. By binding to miR‐124‐3p, it promotes the release of inflammatory cytokines from macrophages, thereby exacerbating the pathological progression of sepsis. The SATB1‐AS1/miR‐124‐3p axis may emerge as a new therapeutic target for sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Emergency and Intensive Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Qinhua Zou
Zitieren
APA
Zhang, L., Gu, Y., Yang, L., & Zou, Q. (2026). Upregulation of lncRNA SATB1‐AS1 in Serum Promotes Sepsis Progression By Suppressing miR‐124‐3p and Enhancing Inflammatory Mediator Release. Journal of Biochemical and Molecular Toxicology, 40(6). https://doi.org/10.1002/jbt.70929
Vancouver
Zhang L, Gu Y, Yang L, Zou Q. Upregulation of lncRNA SATB1‐AS1 in Serum Promotes Sepsis Progression By Suppressing miR‐124‐3p and Enhancing Inflammatory Mediator Release. Journal of Biochemical and Molecular Toxicology. 2026;40(6). doi:10.1002/jbt.70929
BibTeX
@article{Zhang2026,
author = {Zhang, Lihong and Gu, Yi and Yang, Lin and Zou, Qinhua},
title = {Upregulation of lncRNA SATB1‐AS1 in Serum Promotes Sepsis Progression By Suppressing miR‐124‐3p and Enhancing Inflammatory Mediator Release},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {6},
doi = {10.1002/jbt.70929}
}
EUVIMED